Skip to main content

Memantine News

Forest and Merz Announce FDA Approval of Namenda XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

NEW YORK--(BUSINESS WIRE)--Jun 21, 2010 - Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that Namenda XR (memantine hydrochloride) was approved by the U.S. Food and Drug...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Alzheimer's Disease, Autism, Migraine

Memantine patient information at Drugs.com